Media
Our latest press releases and resources for media
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
Key information
2020 Full year and fourth quarter results announcement
We announced our full year and fourth quarter results for the period ended 31 December 2020 on Wednesday 3 February 2021.
Press releases for media
- GSK and Vir Biotechnology announce EMA review of dual-action monoclonal antibody VIR-7831 for the early treatment of COVID-19
- GSK provides update on feladilimab, an investigational inducible T cell co-stimulatory (ICOS) agonist
- GSK announces Dr Anne Beal to join the Board as Non-Executive Director
- GSK to support manufacture of Novavax’ COVID-19 vaccine
GSK Twitter
-
GSK @GSK
#News for #investors and #media: In partnership with @Vir_Biotech, we’re announcing that the @EMA_News is starting a review of a potential new monoclonal antibody therapy for #COVID19. Learn more about our response to the pandemic: gsk.to/2QuCz5H
about 1 day ago -
GSK @GSK
Our industry continues to work tirelessly to combat the #COVID19 pandemic and the rapid spread of new variant strains. Go #BehindTheScience to find out how we’re using our science to fight against these viruses both now and into the future.
about 1 day ago
